Mumprecht et al., for example evaluated responses to 2 different CML models including a chronic (BCR/ABL) and a blast crisis CML (BCR/ABL-NUP98/HOXA9) model that had been previously described (38, 39). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.